← Open Payments lookup

VALORIE MIXON: Open Payments

NPI 1285728006 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$588 in 30 payments from 15 companies in 2025. Trend: 2023 $374 · 2024 $408 · 2025 $588

Food & beverage: $588
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.6$116
Novo Nordisk Inc4$88
Axsome Therapeutics, Inc.2$46
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$43
GlaxoSmithKline, LLC.2$42
Xeris Pharmaceuticals, Inc.2$42
Medtronic, Inc.2$41
Amgen Inc.2$31
Lilly USA, LLC2$31
AstraZeneca Pharmaceuticals LP1$22

Products named: GEMTESA, Auvelity, CAPLYTA, TRELEGY ELLIPTA, GVOKE HYPOPEN, Ozempic, MOUNJARO, Rybelsus.

Industry payments across GA — which companies pay providers there.